Back to Agenda
Session 5: Clarity in Clinical Trials: Unlocking the Potential of Plain Language Summaries for Patients and the Public
Session Chair(s)
Francine Lane, MBA
Senior Director of Product Management
Citeline, United States
Session 5: Clarity in Clinical Trials: Unlocking the Potential of Plain Language Summaries for Patients and the Public
Speaker(s)
Navigating EU CTR: Mastering Effective Lay Protocol Synopses (LPS) and Plain Language Summary (PLS) Development
Representative Invited
Merck Sharp & Dohme LLC, United States
The Value of Plain Language Writing in Clinical Research Operations and Medical Communication
Representative Invited
Daiichi Sankyo, Inc. , United States
Have an account?